Effectiveness and Acceptability of Remote Fine-Tuning of Hearing Aids in Danish Adults
Launched by ZEALAND UNIVERSITY HOSPITAL · May 19, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see how well remote fine-tuning of hearing aids works compared to the traditional method of making adjustments in person. Participants will be divided into two groups: one group will use a smartphone app to adjust their hearing aids from home, while the other group will visit a clinic for face-to-face adjustments. The researchers want to find out if people feel just as satisfied and if their hearing improves similarly with both methods.
To join the study, participants should be adults aged 18 or older who have hearing loss and are comfortable using a smartphone. They need to be able to communicate in Danish and have a reliable internet connection. Over a three-month period, everyone will attend five scheduled appointments to set up and fine-tune their hearing aids. This study is currently recruiting participants, so if you or someone you know fits the criteria, it could be a great opportunity to help improve hearing aid services!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients with hearing loss who desire HA treatment (+18 of age).
- • Danish language skills both written and oral.
- • Acquisition of digital proficiency in terms of being familiar with operating a smartphone, including navigating menus, opening and closing apps, and interacting with the touchscreen with capabilities for audio and video calls.
- • Access to a smartphone that are compatible with manufacturers' system requirements.
- • Access to a stable network connection on the mobile device, with either Wi-Fi or mobile data.
- Exclusion Criteria:
- • Patients with tinnitus requiring treatment or scoring more than 58 in the 'Tinnitus Handicap Inventory' (THI) grading system.
- • Patients with Ménière disease, due to its complications and symptoms as dizziness, balance problems and fluctuating hearing loss, that can affect the HA treatment.
- • Patients who will receive in-the-ear (ITE) hearing aids, due to potential limitations in connectivity for remote fine-tuning.
- • Patients which are recommended/offered unilateral HA treatment.
About Zealand University Hospital
Zealand University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to improve patient outcomes and enhance treatment methodologies. With a commitment to rigorous scientific standards and ethical practices, Zealand University Hospital collaborates with multidisciplinary teams to explore new therapies and interventions, contributing significantly to the global body of medical knowledge. Through its state-of-the-art facilities and focus on patient-centered care, the hospital plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Køge, , Denmark
Patients applied
Trial Officials
Bjarki Ditlev Djurhuus, MD, PhD, Assoc Prof
Study Chair
Zealand University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported